Nundina › Discover calendars › FDA New Drug Approvals calendar › FDA approves Onswik (insulin efsitora alfa-gobe)FDA approves Onswik (insulin efsitora alfa-gobe)23 September 2026The FDA approved Onswik (insulin efsitora alfa-gobe), a biologic from Eli Lilly And CO. Form: Injectable, Subcutaneous. Application BLA761408.FDA New Drug Approvals calendarMore from this calendar

19 October 2026 - FDA approves Calrezdy (calcuim chloride)

19 October 2026 - FDA approves Cienby (sodium ctirate)

16 October 2026 - FDA approves Yulzety (rivaroxaban)

16 October 2026 - FDA approves Brytly (brytly (apraclonidine))

15 October 2026 - FDA approves Evoxac (cevimeline hydrochloride)